Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians

Gerald F Watts^{1

2}, David R Sullivan^{3

4}, David L Hare^{5

6}, Karam M Kostner⁷, Ari E Horton^{8

9

10}, Damon A Bell^{1

2

11

12

13}, Tom Brett¹⁴, Ronald J Trent^{15

16}, Nicola K Poplawski^{17

18}, Andrew C Martin^{19

20}, Shubha Srinivasan^{21

22}, Robert N Justo^{23

24}, Clara K Chow^{25

26

27}, Jing Pang¹; and members of the FH Australasia Network Consensus Working Group

Collaborators, Affiliations

Collaborators

and members of the FH Australasia Network Consensus Working Group:
Zanfina Ademi, Justin J Ardill, Wendy Barnett, Timothy R Bates, Lawrence J Beilin, Warrick Bishop, J Andrew Black, Alex Brown, John R Burnett, Christina A Bursill, Alison Colley, Peter M Clifton, Elif I Ekinci, Gemma A Figtree, Brett H Forge, Jacquie Garton-Smith, Dorothy F Graham, Ian Hamilton-Craig, Christian R Hamilton-Craig, Clare Heal, Charlotte M Hespe, Amanda J Hooper, Laurence G Howes, Jodie Ingles, Edward D Janus, Nadarajah Kangaharan, Anthony C Keech, Andrew B Kirke, Leonard Kritharides, Campbell V Kyle, Paul Lacaze, Stephen Ch Li, Stjepana Maticevic, Brendan M McQuillan, Sam Mirzaee, Trevor A Mori, Allison C Morton, David M Colquhoun, Joanna C Moullin, Paul J Nestel, Kristen J Nowak, Richard C O'Brien, Nicholas Pachter, Michael M Page, Peter J Psaltis, Jan Radford, Nicola J Reid, Elizabeth N Robertson, Jacqueline D M Ryan, Mitchell N Sarkies, Carl J Schultz, Christopher Semsarian, Leon A Simons, Catherine Spinks, Andrew M Tonkin, Frank van Bockxmeer, Kathryn E Waddell-Smith, Natalie C Ward, Harvey D White, Andrew M Wilson, Ingrid Winship, Ann Marie Woodward, Stephen J Nicholls, Luke Elias, Wynand Malan, John Irvin, Kirsten Lambert, Annette Pedrotti

Affiliations

¹ School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
² Lipid Disorders Clinic, Cardiometabolic Service, Departments of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia.
³ Department of Chemical Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
⁴ Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
⁵ Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
⁶ Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.
⁷ Department of Cardiology, Mater Hospital, University of Queensland, Brisbane, Queensland, Australia.
⁸ Monash Heart and Monash Children's Hospital, Monash Health, Melbourne, Victoria, Australia.
⁹ Monash Cardiovascular Research Centre, Melbourne, Victoria, Australia.
¹⁰ Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.
¹¹ Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital and Fiona Stanley Hospital Network, Perth, Western Australia, Australia.
¹² Department of Clinical Biochemistry, Clinipath Pathology, Perth, Western Australia, Australia.
¹³ Sonic Genetics, Sonic Pathology, Sydney, New South Wales, Australia.
¹⁴ General Practice and Primary Health Care Research, School of Medicine, University of Notre Dame Australia, Perth, Western Australia, Australia.
¹⁵ Department of Medical Genomics, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
¹⁶ Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
¹⁷ Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
¹⁸ Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
¹⁹ Department General Paediatrics, Perth Children's Hospital, Perth, Western Australia, Australia.
²⁰ Division of Paediatrics, University of Western Australia, Perth, Western Australia, Australia.
²¹ Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
²² Discipline of Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
²³ Department of Paediatric Cardiology, Queensland Children's Hospital, Brisbane, Queensland, Australia.
²⁴ School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
²⁵ Westmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia.
²⁶ Department of Cardiology, Westmead Hospital, Sydney, New South Wales, Australia.
²⁷ George Institute for Global Health, Sydney, New South Wales, Australia.

PMID: 34047032
DOI: 10.1111/imj.15327

Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians

Gerald F Watts et al. Intern Med J. 2021 May.

. 2021 May;51(5):769-779.

doi: 10.1111/imj.15327.

Authors

Collaborators

and members of the FH Australasia Network Consensus Working Group:
Zanfina Ademi, Justin J Ardill, Wendy Barnett, Timothy R Bates, Lawrence J Beilin, Warrick Bishop, J Andrew Black, Alex Brown, John R Burnett, Christina A Bursill, Alison Colley, Peter M Clifton, Elif I Ekinci, Gemma A Figtree, Brett H Forge, Jacquie Garton-Smith, Dorothy F Graham, Ian Hamilton-Craig, Christian R Hamilton-Craig, Clare Heal, Charlotte M Hespe, Amanda J Hooper, Laurence G Howes, Jodie Ingles, Edward D Janus, Nadarajah Kangaharan, Anthony C Keech, Andrew B Kirke, Leonard Kritharides, Campbell V Kyle, Paul Lacaze, Stephen Ch Li, Stjepana Maticevic, Brendan M McQuillan, Sam Mirzaee, Trevor A Mori, Allison C Morton, David M Colquhoun, Joanna C Moullin, Paul J Nestel, Kristen J Nowak, Richard C O'Brien, Nicholas Pachter, Michael M Page, Peter J Psaltis, Jan Radford, Nicola J Reid, Elizabeth N Robertson, Jacqueline D M Ryan, Mitchell N Sarkies, Carl J Schultz, Christopher Semsarian, Leon A Simons, Catherine Spinks, Andrew M Tonkin, Frank van Bockxmeer, Kathryn E Waddell-Smith, Natalie C Ward, Harvey D White, Andrew M Wilson, Ingrid Winship, Ann Marie Woodward, Stephen J Nicholls, Luke Elias, Wynand Malan, John Irvin, Kirsten Lambert, Annette Pedrotti

Affiliations

¹ School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
² Lipid Disorders Clinic, Cardiometabolic Service, Departments of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia.
³ Department of Chemical Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
⁴ Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
⁵ Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
⁶ Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.
⁷ Department of Cardiology, Mater Hospital, University of Queensland, Brisbane, Queensland, Australia.
⁸ Monash Heart and Monash Children's Hospital, Monash Health, Melbourne, Victoria, Australia.
⁹ Monash Cardiovascular Research Centre, Melbourne, Victoria, Australia.
¹⁰ Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.
¹¹ Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital and Fiona Stanley Hospital Network, Perth, Western Australia, Australia.
¹² Department of Clinical Biochemistry, Clinipath Pathology, Perth, Western Australia, Australia.
¹³ Sonic Genetics, Sonic Pathology, Sydney, New South Wales, Australia.
¹⁴ General Practice and Primary Health Care Research, School of Medicine, University of Notre Dame Australia, Perth, Western Australia, Australia.
¹⁵ Department of Medical Genomics, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
¹⁶ Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
¹⁷ Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
¹⁸ Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
¹⁹ Department General Paediatrics, Perth Children's Hospital, Perth, Western Australia, Australia.
²⁰ Division of Paediatrics, University of Western Australia, Perth, Western Australia, Australia.
²¹ Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
²² Discipline of Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
²³ Department of Paediatric Cardiology, Queensland Children's Hospital, Brisbane, Queensland, Australia.
²⁴ School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
²⁵ Westmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia.
²⁶ Department of Cardiology, Westmead Hospital, Sydney, New South Wales, Australia.
²⁷ George Institute for Global Health, Sydney, New South Wales, Australia.

PMID: 34047032
DOI: 10.1111/imj.15327

Abstract

Familial hypercholesterolaemia (FH) is a common, heritable and preventable cause of premature coronary artery disease. New clinical practice recommendations are presented to assist practitioners in enhancing the care of all patients with FH. Core recommendations are made on the detection, diagnosis, assessment and management of adults, children and adolescents with FH. Management is under-pinned by the precepts of risk stratification, adherence to healthy lifestyles, treatment of non-cholesterol risk factors and appropriate use of low-density lipoprotein (LDL)-cholesterol-lowering therapies including statins, ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. The recommendations need to be utilised using judicious clinical judgement and shared decision-making with patients and families. New government-funded schemes for genetic testing and use of PCSK9 inhibitors, as well as the National Health Genomics Policy Framework, will enable adoption of the recommendations. However, a comprehensive implementation science and practice strategy is required to ensure that the guidance translates into benefit for all families with FH.

Keywords: adults; care; familial hypercholesterolaemia; guidance; management; prevention.

PubMed Disclaimer

References

1. Watts GF, Gidding SS, Mata P, Pang J, Sullivan DR, Yamashita S et al. Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care. Nat Rev Cardiol 2020; 17: 360-77.
1. Pang J, Sullivan DR, Brett T, Kostner KM, Hare DL, Watts GF. Familial hypercholesterolaemia in 2020: a leading tier 1 genomic application. Heart Lung Circ 2020; 29: 619-33.
1. Watts GF, Sullivan DR, Hare DL, Kostner KM, Horton AE, Bell DA et al. Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia. Heart Lung Circ 2020; 30: 324-49.
1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.
1. Gidding SS, Champagne MA, de Ferranti SD, Defesche J, Ito MK, Knowles JW et al. The agenda for familial hypercholesterolemia - a scientific statement from the American Heart Association. Circulation 2015; 132: 2167-92.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians

Collaborators

Affiliations

Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians

Authors

Collaborators

Affiliations

Abstract

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous